Navigation Links
New technology aids in prostate cancer treatment
Date:5/12/2010

KINGTON, ON Researchers at Queen's University have developed a new way of performing lab tests that could improve the way doctors manage prostate cancer treatment. It will allow them to identify with unprecedented accuracy losses of a gene called PTEN that is associated with an aggressive group of prostate cancers.

The improved Fluorescence In-Situ Hybridization (FISH) platform uses DNA probes to analyze the three-dimensional space cancer cells occupy in routine clinical microscopic analysis of tissue sections of tumors. It will provide a more accurate way of identifying PTEN loss in biopsies and tissue sections so doctors can better match the type and amount of treatment to the aggressiveness of a tumor.

"The idea is that this test could be used in new cases of prostate cancer to help decide which of the many options is best suited for more aggressive cancers " says Jeremy Squire, who worked with a team of researchers in the Department of Pathology and Molecular Medicine. "The patient treatment from the get-go will be more appropriately planned."

PTEN is found in the nucleus of cancer cells and is considered one of the most important cancer-causing tumor-suppressor genes. If there is loss in the PTEN, it can inhibit the patient's ability to fight the cancer. It plays a critical role in a variety of cancers including prostate, breast, and lung cancers.

PARTEQ Innovations, the technology transfer office of Queen's University has licensed the technology to Cymogen Dx. The company expects to make the technology available to research and clinical markets in the near future.


'/>"/>

Contact: Kristyn Wallace
kristyn.wallace@queensu.ca
61-353-360-007-9173
Queen's University
Source:Eurekalert

Page: 1

Related medicine news :

1. CosmoCom Technology Helps Unify Public Health Services in Spain
2. Tattoo Removal Laser Clinic Announces New PhotoAcoustic Laser Technology
3. PHSI LLC Announces the Addition of New Technology from Audina Hearing Instruments
4. Hayes, Inc. Technology Prognosis Team Tracks First-of-a-Kind Technologies
5. Agricultural Biotechnology Addresses Consumer Demands for Healthier Foods
6. Innovative Technology Developed at AGH Accurately Monitors Healthcare Professionals' Handwashing Practices, Study Shows
7. Preventing blindness focus of ORNL technology, AMDx
8. Over 450 Patients Now Toenail Fungus Free Thanks to Your Next Step's New Toenail Fungus Laser Treatment Technology
9. Survey: Hiding risks can hurt public support for nanotechnology
10. Ross Nanotechnology Corporation Introduces the NeverWet™ Coating on its First Consumer Product – The Clear-n-Clean Plunger
11. "IPGDx, LLC Announces The Continued Validation Of Its Patented Technology For The Assessment Of Prognosis; PrognostiCheck" Getting the New Information to Patients and Do
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... March 29, 2017 , ... The Wharton School of ... Julie Taffet Moelis, W’81, have made a $10 million gift to establish the ... that will provide a pathway to a Wharton MBA for highly-qualified Penn undergraduates whose ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 ... the only option for on-premises installation of its Help System for SharePoint was at ... the system into the entire tenant. , The company recently released a modified ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, ... public to take the Diabetes Risk Test to find out if they are at ... World Airports will light up the evening sky by programming the LAX pylons the ...
(Date:3/28/2017)... NEW YORK, NEW YORK (PRWEB) , ... March ... ... their breakthrough development, NTX Technology™, is the first technology to directly address the ... World Health Organization. NTX Technology™ is a patented compound of FDA and TTB ...
(Date:3/28/2017)... ... 2017 , ... Resoundant, Inc., the developer of Magnetic ... annual customer education symposium, a world-class learning conference that offers educational content designed ... 31, 2017 at the Atlanta Marriott Marquis in Atlanta, Georgia. , Innovations for ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... Market Outlook: 2016-2022" report to their offering. ... The global patient safety and ... delivery, end-user, and geography. Patient safety has become ... The field has developed significantly in the last decade and is ...
(Date:3/28/2017)... , March 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – ... the disease and global market trends of the Chemotherapy Induced Neutropenia ... , Europe ( France , ... Spain , UK) and Japan , ... and rest of the world (RoW). The Report covers ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: